Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes
11:42am, Wednesday, 10'th Aug 2022 Benzinga
RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday.
Piper Sandler increased the price target on Masimo Corpo
Masimo's (MASI) Q2 Earnings Surpass Estimates, Margins Down
11:17am, Wednesday, 10'th Aug 2022
Masimo's (MASI) robust product shipments and strength in its healthcare business drive its Q2 sales.
Masimo (MASI) Q2 2022 Earnings Call Transcript
09:00am, Wednesday, 10'th Aug 2022 The Motley Fool
MASI earnings call for the period ending June 30, 2022.
Masimo (MASI) Q2 Earnings and Revenues Top Estimates
11:25pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Masimo (MASI) delivered earnings and revenue surprises of 13.45% and 4.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Masimo Corporation (MASI) CEO Joe Kiani on Q2 2022 Results - Earnings Call Transcript
10:27pm, Tuesday, 09'th Aug 2022
Masimo Corporation (NASDAQ:MASI ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development and Investor Relations Joe Kiani
Masimo (MASI) Q2 Earnings and Revenues Top Estimates
09:04pm, Tuesday, 09'th Aug 2022
Masimo (MASI) delivered earnings and revenue surprises of 13.45% and 4.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Investors Like the News From These Companies
11:51am, Tuesday, 09'th Aug 2022 The Motley Fool
Apple, Microsoft, Alphabet, and Amazon provide a welcome lift to the market.
RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Monday, 08'th Aug 2022 Zacks Investment Research
RxSight, Inc. (RXST) delivered earnings and revenue surprises of 26.47% and 0.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Q2 Earnings and Revenues Surpass Estimates
11:15am, Wednesday, 03'rd Aug 2022 Zacks Investment Research
LivaNova (LIVN) delivered earnings and revenue surprises of 3.92% and 2.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
IRadimed (IRMD) Beats Q2 Earnings and Revenue Estimates
04:25pm, Friday, 29'th Jul 2022 Zacks Investment Research
iRadimed (IRMD) delivered earnings and revenue surprises of 12.50% and 0.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Masimo to Report Second Quarter 2022 Financial Results after Market Close on Tuesday, August 9
04:15pm, Tuesday, 26'th Jul 2022
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release second quarter 2022 financial results for the period ended July 2, 2022, after the market closes on Tuesday, August 9, 2022. The con
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
11:56am, Tuesday, 19'th Jul 2022 Zacks Investment Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
1 Highly Underrated Moat in Growth Stocks
01:45pm, Friday, 15'th Jul 2022 The Motley Fool
Moats provide companies with a sustainable competitive advantage, and this underrated pricing edge is one of the strongest moats in the business world.
Study Favors Masimo's (MASI) SafetyNet for Better Patient Outcome
03:33pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Masimo's (MASI) SafetyNet is expected to reduce the duration of hospitalization for COVID-19 patients and create more bed capacity in hospitals.
Study Favors Masimo's (MASI) SafetyNet for Better Patient Outcome
01:13pm, Wednesday, 06'th Jul 2022
Masimo's (MASI) SafetyNet is expected to reduce the duration of hospitalization for COVID-19 patients and create more bed capacity in hospitals.
